Concepedia

Mark Horn

MH

Statistics

Publications

4

Citations

247

H-Index

4

Active since

2012

Affiliations

Pfizer (United States)(Current)

Mark Horn is an author at Pfizer (United States) specializing in drug discovery, endocrinology, and pharmacy.

Publications per year

2012–2017

4

Publications

4

Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay

J. Perry Hall, Amy Brault, Fabien Vincent et al. · PLoS ONE · 2017 · 162 citations · Full text

, , +17

The Effect of Molecular Weight, PK, and Valency on Tumor Biodistribution and Efficacy of Antibody-Based Drugs

Ruth Muchekehu, Dingguo Liu, Mark Horn et al. · Translational Oncology · 2013 · 37 citations · Full text

, , +17

Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption

Kristen Johnson, Kymberly K. Levine, Joseph A. Sergi et al. · Journal of Bone and Mineral Research · 2017 · 32 citations · Full text

, , +17

Development of a long acting human growth hormone analog suitable for once a week dosing

Moorthy S. S. Palanki, Abhijit Bhat, Ben Bolaños et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 16 citations

, , +10

1–4 of 4